pub2005

Written publications

Peer-reviewed articles:

Andersen J, Heilmann C, Jacobsen N, Bendtzen K, Müller K. Cytokines and soluble tumour necrosis factor I receptor levels during pretransplant conditioning in allogeneic stem-cell transplantation. Int Immunopharmacol 2005;5:67-71.

Bjornhart B, Svenningsen P, Gudbrandsdottir S, Zak M, Nielsen S, Bendtzen K, Müller K. Plasma TNF binding capacity in patients with juvenile idiopathic arthritis. Int Immunopharmacol 2005;5:73-77.

Conget I, Aguilera E, Pellitero S, Näf S, Bendtzen K, Casamitjana R, Gomis R, Nicoletti F. Lack of effect of intermittently administered sodium fusidate to patients with newly diagnosed type 1 diabetes mellitus: the FUSIDIM trial. Diabetologia 2005;48:1464-1468.

Grauballe MC, Bentzen BH, Bjornsson M, Moe D, Jonassen TE, Bendtzen K, Stoltze K, Holmstrup P. The effect of spironolactone on experimental periodontitis in rats. J Periodontal Res 2005;40:212-217.

Lindqvist E, Eberhardt K, Bendtzen K, Heinegard D, Saxne T. Prognostic laboratory markers of joint damage in rheumatoid arthritis. Ann Rheum Dis 2005;64:196-201.

Sorensen PS, Koch-Henriksen N, Ross C, Clemmesen KM, Bendtzen K, The Danish Multiple Sclerosis Study Group. Appearance and disappearance of neutralizing antibodies during interferon-beta therapy. Neurology 2005;65:33-39.

Takahashi N, Rieneck K, van der Kraan PM, van Beuningen HM, Vitters EL, Bendtzen K, van den Berg WB. Elucidation of IL-1/TGF-beta interactions in mouse chondrocyte cell line by genome-wide gene expression. Osteoarthritis Cartilage 2005;13:426-38.

Articles in press:

Mikkelsen M, Sønder SU, Nersting J, Bendtzen K. Spironolactone induces apoptosis in human mononuclear cells. Association between apoptosis and cytokine suppression. Apoptosis 2005.

Nielsen CH, Moeller AC, Hegedüs L, Bendtzen K, Leslie RGQ. Self-reactive CD4+ T cells and B cells in the blood in health and autoimmune disease; increased frequency of thyroglobulin-reactive cells in Graves' disease. J Clin Immunol 2005.

Ross C, Svenson M, Clemmesen KM, Sorensen PS, Koch-Henriksen N, Bendtzen K. Measuring and evaluating interferon-beta-induced antibodies in patients with multiple sclerosis. Mult Scler 2005.

Sellebjerg F, Ross C, Koch-Henriksen N, Sorensen PS, Frederiksen JL, Bendtzen K, Sorensen TL. CD26+CD4+ T cell counts and attack risk in interferon-treated multiple sclerosis. Mult Scler 2005.

Sønder SU, Mikkelsen M, Rieneck K, Hedegaard CJ, Bendtzen K. Spironolactone induced apoptosis in human blood mononuclear cells. Effects on apoptosis related and immunoinflammatory genes are mineralocorticoid receptor independent. Br J Pharmacol 2005. Supplementary materials: Table s1, and Figure s1 and Figure s2 on our website.

This site is part of a frame. If you arrived to this page directly, click here!

2005

Written publications

Peer-reviewed articles:

Andersen J, Heilmann C, Jacobsen N, Bendtzen K, Müller K. Cytokines and soluble tumour necrosis factor I receptor levels during pretransplant conditioning in allogeneic stem-cell transplantation. Int Immunopharmacol 2005;5:67-71.

Bjornhart B, Svenningsen P, Gudbrandsdottir S, Zak M, Nielsen S, Bendtzen K, Müller K. Plasma TNF binding capacity in patients with juvenile idiopathic arthritis. Int Immunopharmacol 2005;5:73-77.

Conget I, Aguilera E, Pellitero S, Näf S, Bendtzen K, Casamitjana R, Gomis R, Nicoletti F. Lack of effect of intermittently administered sodium fusidate to patients with newly diagnosed type 1 diabetes mellitus: the FUSIDIM trial. Diabetologia 2005;48:1464-1468.

Grauballe MC, Bentzen BH, Bjornsson M, Moe D, Jonassen TE, Bendtzen K, Stoltze K, Holmstrup P. The effect of spironolactone on experimental periodontitis in rats. J Periodontal Res 2005;40:212-217.

Lindqvist E, Eberhardt K, Bendtzen K, Heinegard D, Saxne T. Prognostic laboratory markers of joint damage in rheumatoid arthritis. Ann Rheum Dis 2005;64:196-201.

Sorensen PS, Koch-Henriksen N, Ross C, Clemmesen KM, Bendtzen K, The Danish Multiple Sclerosis Study Group. Appearance and disappearance of neutralizing antibodies during interferon-beta therapy. Neurology 2005;65:33-39.

Takahashi N, Rieneck K, van der Kraan PM, van Beuningen HM, Vitters EL, Bendtzen K, van den Berg WB. Elucidation of IL-1/TGF-beta interactions in mouse chondrocyte cell line by genome-wide gene expression. Osteoarthritis Cartilage 2005;13:426-38.

Articles in press:

Mikkelsen M, Sønder SU, Nersting J, Bendtzen K. Spironolactone induces apoptosis in human mononuclear cells. Association between apoptosis and cytokine suppression. Apoptosis 2005.

Nielsen CH, Moeller AC, Hegedüs L, Bendtzen K, Leslie RGQ. Self-reactive CD4+ T cells and B cells in the blood in health and autoimmune disease; increased frequency of thyroglobulin-reactive cells in Graves' disease. J Clin Immunol 2005.

Ross C, Svenson M, Clemmesen KM, Sorensen PS, Koch-Henriksen N, Bendtzen K. Measuring and evaluating interferon-beta-induced antibodies in patients with multiple sclerosis. Mult Scler 2005.

Sellebjerg F, Ross C, Koch-Henriksen N, Sorensen PS, Frederiksen JL, Bendtzen K, Sorensen TL. CD26+CD4+ T cell counts and attack risk in interferon-treated multiple sclerosis. Mult Scler 2005.

Sønder SU, Mikkelsen M, Rieneck K, Hedegaard CJ, Bendtzen K. Spironolactone induced apoptosis in human blood mononuclear cells. Effects on apoptosis related and immunoinflammatory genes are mineralocorticoid receptor independent. Br J Pharmacol 2005. Supplementary materials: Table s1, and Figure s1 and Figure s2 on our website.